ASAH1 Protein

ASAH1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ASAH1 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ASAH1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ASAH1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=ASAH1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/lysosomal-storage-disorder-gene-variants" style="color:#ef9a9a">LYSOSOMAL STORAGE DISORDER GENE VARIANTS</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson's-disease" style="color:#ef9a9a">PARKINSON'S DISEASE</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>

Asah1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

ASAH1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ASAH1 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ASAH1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ASAH1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=ASAH1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/lysosomal-storage-disorder-gene-variants" style="color:#ef9a9a">LYSOSOMAL STORAGE DISORDER GENE VARIANTS</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson's-disease" style="color:#ef9a9a">PARKINSON'S DISEASE</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>

Asah1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

ASAH1 (N-Acylsphingosine Amidohydrolase 1), also known as acid ceramidase, is a lysosomal enzyme that hydrolyzes the lipid signaling molecule ceramide into sphingosine and free fatty acids. This reaction is part of the sphingolipid metabolism pathway, which is critically important for neuronal function and survival. ASAH1 deficiency causes Farber disease, a lysosomal storage disorder with severe neurological manifestations, and the protein has been implicated in the pathogenesis of various neurodegenerative diseases including Parkinson's disease and amyotrophic lateral sclerosis. [@albou2013]

Molecular Characteristics

ASAH1 is a lysosomal hydrolase belonging to the family of N-acylethanolamine-hydrolyzing acid amidases. The enzyme functions as a heterodimer composed of alpha and beta subunits derived from a single precursor polypeptide. [@dinkins2014]

Structural Features

• Molecular Weight:
• Precursor: ~53 kDa
• Alpha subunit: ~13 kDa
• Beta subunit: ~40 kDa
• Subcellular Localization: Lysosomes
• Conserved Domains:
• Signal peptide
• Propeptide (cleaved to form active enzyme)
• Catalytic domain with amidase signature

Isoforms

• ASAH1A: Ubiquitously expressed isoform
• ASAH1B: Brain-enriched isoform

Biological Functions

Ceramide Metabolism

ASAH1 catalyzes the hydrolysis of ceramide: [@he2015]

• Reaction: Ceramide + H2O → Sphingosine + Fatty acid
• Location: Lysosomal compartment
• pH Optimum: Acidic (pH 4.5-5.5)

Sphingolipid Signaling

The products of ASAH1 catalysis are bioactive lipid mediators: [@liu2020]

• Sphingosine: Precursor for sphingosine-1-phosphate (S1P), a pro-survival signaling molecule
• Free fatty acids: Used for energy metabolism or membrane remodeling

Lysosomal Function

ASAH1 is essential for lysosomal lipid homeostasis: [@mancuso2020]

• Prevents accumulation of cytotoxic ceramide
• Maintains proper lysosomal membrane composition
• Supports autophagic flux

Role in Neurodegeneration

Farber Disease

ASAH1 mutations cause Farber disease, a lysosomal storage disorder characterized by:

• Ceramide accumulation in tissues
• Progressive motor and cognitive decline
• Early-onset neurodegeneration
• Arthritis and skin nodules

Parkinson's Disease

ASAH1 has been strongly implicated in Parkinson's disease pathogenesis:

• PD brains show altered ceramide levels
• ASAH1 activity is reduced in PD substantia nigra
• Ceramide accumulation promotes dopaminergic neuron death

• Ceramide promotes alpha-synuclein aggregation
• ASAH1 overexpression reduces alpha-synuclein toxicity
• Sphingosine-1-phosphate has neuroprotective effects

• Ceramide induces mitochondrial dysfunction
• ASAH1 protects against ceramide-induced [apoptosis](/entities/apoptosis)
• Modulates mitophagy pathways

Amyotrophic Lateral Sclerosis (ALS)

ASAH1 may contribute to ALS through:

• Ceramide-mediated motor neuron death
• Impaired [autophagy](/entities/autophagy)-lysosome pathway
• Altered lipid metabolism in motor [neurons](/entities/neurons)

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), ASAH1 may play roles through:

• Amyloid-induced ceramide elevation
• Ceramide's effects on [tau](/proteins/tau) phosphorylation
• Neuronal apoptosis mechanisms

Mechanisms of Neurodegeneration

• Cytotoxic ceramide buildup
• Endoplasmic reticulum stress
• Apoptotic cell death

• Reduced S1P production
• Loss of neuroprotective signaling
• Impaired cell survival pathways

• Autophagic impairment
• Accumulation of lipid droplets
• Disrupted cellular homeostasis

Therapeutic Implications

Target Potential

ASAH1 represents a significant therapeutic target:

• Recombinant ASAH1 delivery
• Gene therapy approaches
• Small molecule activators

• Ceramide synthesis inhibitors
• Sphingosine-1-phosphate receptor agonists

• Antioxidant strategies
• Anti-apoptotic approaches

Clinical Trials

• Recombinant human ASAH1 (Pegunigalsidase alfa) has been developed for Fabry disease
• Gene therapy approaches are in development

Clinical Relevance

Genetic Testing

ASAH1 mutations can be identified through:

• Targeted gene panels for neurodegenerative diseases
• Whole exome sequencing
• Enzyme activity assays

Biomarkers

• Plasma/CSF ceramide levels
• ASAH1 activity measurements
• Lysosomal function markers

Interactions and Pathways

ASAH1 interacts with several key proteins and pathways:

• CERS (Ceramide Synthases): Ceramide production
• SGMS (Sphingomyelin Synthases): Ceramide metabolism
• S1PR (S1P Receptors): Downstream signaling
• [GBA1](/entities/gba) (Glucocerebrosidase): Lysosomal lipid metabolism
• ATG proteins: Autophagy pathway

See Also

• [ASAH1 Gene](/genes/asah1) - Gene page
• [Proteins](/proteins) - All protein pages
• [Genes](/genes) - All gene pages
• [Ceramide Metabolism in Neurodegeneration](/mechanisms/ceramide-metabolism-neurodegeneration)
• [Sphingolipid Signaling](/mechanisms/sphingolipid-signaling)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)

Background

The study of Asah1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References